Intellia Therapeutics Inc buy Stifel Nicolaus
Start price
11.09.24
/
50%
€18.23
Target price
11.09.25
€58.07
Performance (%)
-46.91%
End price
12.09.25
€9.68
Summary
This prediction ended on 12.09.25 with a price of €9.68. Massive losses of -46.91% were the result for the BUY prediction by Stifel_Nicolaus. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.654% | -3.654% | 8.984% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Stifel Nicolaus from $80.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten